Patent ID: 11873335
Assignee: PHANES THERAPEUTICS, INC.
Field: Measurement (Instruments)
Classification: CPC C  G  A | IPC A  C  G

Claim 0:
1. An isolated monoclonal antibody or antigen-binding fragment thereof comprising a heavy chain complementarity determining region 1 (HCDR1), HCDR2, HCDR3, a light chain complementarity determining region 1 (LCDR1), LCDR2, and LCDR3, having the polypeptide sequence of:
(a) SEQ ID NOs: 29, 30, 31, 53, 54 and 55, respectively, or SEQ ID NOs: 77, 78, 79, 101, 102, and 103, respectively;
(b) SEQ ID NOs: 20, 21, 22, 44, 45 and 46, respectively, or SEQ ID NOs: 68, 69, 70, 92, 93, and 94, respectively; or
(c) SEQ ID NOs: 35, 36, 37, 59, 60 and 61, respectively, or SEQ ID NOs: 83, 84, 85, 107, 108, and 109, respectively;, wherein the antibody or antigen-binding fragment thereof specifically binds FOLR1.